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Objectives The aim of this study was to examine the effects of sarcoplasmic reticulum
Ca2+ ATPase (SERCA2a) gene transfer in a swine heart failure (HF)
model.Background Reduced expression and activity of SERCA2a have been
documented in HF. Prior studies have reported the beneficial effects of short-term
SERCA2a overexpression in rodent models. However, the effects of long-term
expression of SERCA2a in pre-clinical large animal models are not known. Methods
Yorkshire-Landrace pigs were used (n = 16) to create volume overload by
percutaneously severing chordae tendinae of the mitral apparatus with a bioptome to
induce mitral regurgitation. At 2 months, pigs underwent intracoronary delivery of
either recombinant adeno-associated virus type 1 (rAAV1) carrying SERCA2a under a
cytomegalovirus promoter (rAAV1.SERCA2a) (n = 10; group 1) or saline (n = 6;
group 2). Results At 2 months, study animals were found to be in a compensated
state of volume-overload HF (increased left ventricular internal diastolic and systolic
diameters [LVIDd and LVIDs]). At 4 months, gene transfer resulted in: 1) positive left
ventricular (LV) inotropic effects (adjusted peak left ventricular pressure rate of rise
(dP/dt)max/P, 21.2 ± 3.2 s−1 group 1 vs. 15.5 ± 3.0 s−1 group 2; p < 0.01); 2)
improvement in LV remodeling (% change in LVIDs −3.0 ± 10% vs. +15 ± 11%,
respectively; p < 0.01). At follow-up, brain natriuretic peptide levels remained stable
in group 1 after gene transfer, in contrast to rising levels in group 2. Further, cardiac
SERCA2a expression was significantly decreased in group 2 whereas in group 1 it
was restored to normal levels. There was no histopathological evidence of acute
myocardial inflammation or necrosis. Conclusions Using a large-animal, volume-
overload model of HF, we report that long-term overexpression of SERCA2a by in
vivo rAAV1-mediated intracoronary gene transfer preserved systolic function,
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